J. van Vliet

Third national biobank for population-based seroprevalence studies in the Netherlands, including the Caribbean Netherlands

H. D. de Melker, L. Mollema, F. R. van der Klis, 2019, BMC Infectious Diseases.

Persistence of Antibodies to Severe Acute Respiratory Syndrome Coronavirus 2 in Relation to Symptoms in a Nationwide Prospective Study

M. van Boven, H. D. de Melker, E. Sanders, 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Nationwide seroprevalence of SARS-CoV-2 and identification of risk factors in the general population of the Netherlands during the first epidemic wave

M. van Boven, H. D. de Melker, L. Mollema, 2020, Journal of Epidemiology & Community Health.

Seropositivity to Nucleoprotein to detect mild and asymptomatic SARS-CoV-2 infections: A complementary tool to detect breakthrough infections after COVID-19 vaccination?

M. van Boven, H. D. de Melker, R. V. Van BInnendijk, 2022, Vaccine.

Seropositivity to Nucleoprotein to detect SARS-CoV-2 infections: a tool to detect breakthrough infections after COVID-19 vaccination

M. van Boven, H. D. de Melker, C. Reusken, 2021, medRxiv.

SARS-CoV-2 Spike S1-specific IgG kinetic profiles following mRNA or vector-based vaccination in the general Dutch population show distinct kinetics

M. van Boven, H. D. de Melker, R. V. Van BInnendijk, 2022, Scientific Reports.

Colistin-resistant Enterobacterales among veterinary healthcare workers and in the Dutch population

A. V. van Hoek, C. Dierikx, P. Hengeveld, 2022, JAC-antimicrobial resistance.

Circulation of pertussis and poor protection against diphtheria among middle-aged adults in 18 European countries

M. Avdičová, Z. Molnár, S. Brisse, 2020, Nature Communications.

Reduced Antibody Acquisition with Increasing Age following Vaccination with BNT162b2: Results from Two Longitudinal Cohort Studies in The Netherlands

W. Verschuren, A. Buisman, R. V. Van BInnendijk, 2022, Vaccines.

Reduced antibody acquisition with increasing age following vaccination with BNT162b2: results from a large study performed in the general population aged 12 to 92 years

R. V. Van Bergen, W. Verschuren, A. Buisman, 2022, medRxiv.

SARS-CoV-2 Spike S1-specific IgG kinetic profiles following mRNA- versus vector-based vaccination in the general Dutch population

M. van Boven, H. D. de Melker, R. V. Van BInnendijk, 2021, medRxiv.

No evidence found for an increased risk of long-term fatigue following human papillomavirus vaccination of adolescent girls.

H. D. de Melker, M. Sturkenboom, J. Kemmeren, 2018, Vaccine.